Pharma Deals Review, Vol 2003, No 33 (2003)

Font Size:  Small  Medium  Large

GSK Licenses Rights to Preclinical HIV Compound

Business Review Editor

Abstract


GlaxoSmithKline signed a development and licensing agreement with Ono Pharmaceutical for the development and commercialization of Ono’s cellular chemokine receptor (CCR5) antagonist, ONO-4128. ONO-4128 is currently in preclinical development for HIV.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.